These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 20238120)

  • 1. Adjunctive valproate in panic disorder patients with comorbid bipolar disorder or otherwise resistant to standard antidepressants: a 3-year "open" follow-up study.
    Perugi G; Frare F; Toni C; Tusini G; Vannucchi G; Akiskal HS
    Eur Arch Psychiatry Clin Neurosci; 2010 Oct; 260(7):553-60. PubMed ID: 20238120
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of adjunctive gabapentin in resistant bipolar disorder: is it due to anxious-alcohol abuse comorbidity?
    Perugi G; Toni C; Frare F; Ruffolo G; Moretti L; Torti C; Akiskal HS
    J Clin Psychopharmacol; 2002 Dec; 22(6):584-91. PubMed ID: 12454558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of anxiety disorder comorbidity on treatment resistant bipolar disorders.
    Lee JH; Dunner DL
    Depress Anxiety; 2008; 25(2):91-7. PubMed ID: 17311265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective naturalistic study of 326 panic-agoraphobic patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Vitale B; Mengali F; Recchia M; Serra G; Akiskal HS
    Pharmacopsychiatry; 2000 Jul; 33(4):121-31. PubMed ID: 10958260
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Demographic and clinical features of panic disorder comorbid with bipolar I disorder: a 3-year retrospective study.
    Nardi AE; Nascimento I; Freire RC; Veras AB; de-Melo-Neto VL; Valença AM; Lopes FL; Soares-Filho GL; Levitan MN; de Carvalho MR; da Costa RT; King AL; Mezzasalma MA; Grivet LO; Rassi A; Versiani M
    J Affect Disord; 2008 Feb; 106(1-2):185-9. PubMed ID: 17604118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of aripiprazole adjunctive to lithium or valproate in the long-term treatment of patients with bipolar I disorder with an inadequate response to lithium or valproate monotherapy: a multicenter, double-blind, randomized study.
    Marcus R; Khan A; Rollin L; Morris B; Timko K; Carson W; Sanchez R
    Bipolar Disord; 2011 Mar; 13(2):133-44. PubMed ID: 21443567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of divalproex sodium in patients with panic disorder and mood instability who have not responded to conventional therapy.
    Baetz M; Bowen RC
    Can J Psychiatry; 1998 Feb; 43(1):73-7. PubMed ID: 9494751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacotherapy for bipolar disorder and comorbid conditions: baseline data from STEP-BD.
    Simon NM; Otto MW; Weiss RD; Bauer MS; Miyahara S; Wisniewski SR; Thase ME; Kogan J; Frank E; Nierenberg AA; Calabrese JR; Sachs GS; Pollack MH;
    J Clin Psychopharmacol; 2004 Oct; 24(5):512-20. PubMed ID: 15349007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and research implications of panic-bipolar comorbidity in children and adolescents.
    Masi G; Perugi G; Millepiedi S; Toni C; Mucci M; Bertini N; Pfanner C; Berloffa S; Pari C; Akiskal K; Akiskal HS
    Psychiatry Res; 2007 Sep; 153(1):47-54. PubMed ID: 17602754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anxiety disorders in 318 bipolar patients: prevalence and impact on illness severity and response to mood stabilizer.
    Henry C; Van den Bulke D; Bellivier F; Etain B; Rouillon F; Leboyer M
    J Clin Psychiatry; 2003 Mar; 64(3):331-5. PubMed ID: 12716276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacological response in juvenile bipolar disorder subtypes: A naturalistic retrospective examination.
    Masi G; Perugi G; Millepiedi S; Mucci M; Pfanner C; Berloffa S; Pari C; Gagliano A; D'Amico F; Akiskal HS
    Psychiatry Res; 2010 May; 177(1-2):192-8. PubMed ID: 20381170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is bipolar disorder still underdiagnosed? Are antidepressants overutilized?
    Ghaemi SN; Sachs GS; Chiou AM; Pandurangi AK; Goodwin K
    J Affect Disord; 1999; 52(1-3):135-44. PubMed ID: 10357026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Goldberg JF; Perlis RH; Ghaemi SN; Calabrese JR; Bowden CL; Wisniewski S; Miklowitz DJ; Sachs GS; Thase ME
    Am J Psychiatry; 2007 Sep; 164(9):1348-55. PubMed ID: 17728419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous treatment discontinuation in panic disorder patients treated with antidepressants.
    Toni C; Perugi G; Frare F; Mata B; Akiskal HS
    Acta Psychiatr Scand; 2004 Aug; 110(2):130-7. PubMed ID: 15233713
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is intravenous valproate more efficacious than oral valproate for inpatients with bipolar I disorder with a manic or depressive episode and concomitant symptoms of opposite polarity?
    Cuomo A; Barillà G; Cattolico M; Carmellini P; Spiti A; Pozza A; Fagiolini A
    Bipolar Disord; 2024 May; 26(3):277-283. PubMed ID: 37957926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized, double-blind, placebo-controlled study of ziprasidone monotherapy in bipolar disorder with co-occurring lifetime panic or generalized anxiety disorder.
    Suppes T; McElroy SL; Sheehan DV; Hidalgo RB; Cosgrove VE; Gwizdowski IS; Feldman NS
    J Clin Psychiatry; 2014 Jan; 75(1):77-84. PubMed ID: 24345758
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription patterns of psychotropic medications in elderly compared with younger participants who achieved a "recovered" status in the systematic treatment enhancement program for bipolar disorder.
    Al Jurdi RK; Marangell LB; Petersen NJ; Martinez M; Gyulai L; Sajatovic M
    Am J Geriatr Psychiatry; 2008 Nov; 16(11):922-33. PubMed ID: 18978253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexity of pharmacologic treatment required for sustained improvement in outpatients with bipolar disorder.
    Post RM; Altshuler LL; Frye MA; Suppes T; Keck PE; McElroy SL; Leverich GS; Luckenbaugh DA; Rowe M; Pizzarello S; Kupka RW; Grunze H; Nolen WA
    J Clin Psychiatry; 2010 Sep; 71(9):1176-86; quiz 1252-3. PubMed ID: 20923622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The clinical-familial correlates and naturalistic outcome of panic-disorder-agoraphobia with and without lifetime bipolar II comorbidity.
    Toni C; Perugi G; Frare F; Tusini G; Fountoulakis KN; Akiskal KK; Akiskal HS
    Ann Gen Psychiatry; 2008 Nov; 7():23. PubMed ID: 19014559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.